http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108117553-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fb38ebd40c70e97cc5f1519c6699162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9713daa9605d3efbe3c1c50dbb5453c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6463c3bba1e55aae601893268831449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb15b77459302be3b355f11739fdc31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a3ed68c61b5680bd44bdea511137ea2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b3bfcac40f5187b582745d70b93947d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c312fdb273a08777e0268f1beef175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88772a7f93b9c796eee111c5a1132da3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9499716fb93cfaed327622f9cf3264fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a9fb5b6b3ce0094930d8aed6d998c35
publicationDate 2018-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108117553-A
titleOfInvention Alkynephenylbenzenesulfonamides Selective ZAK Inhibitors and Their Applications
abstract The present invention relates to the application of alkynephenylbenzenesulfonamide compounds with the structure of formula (I) or pharmaceutically acceptable salts or stereoisomers or prodrug molecules thereof in the preparation of ZAK inhibitors. The alkyne phenylbenzene sulfonamide compound can effectively and highly selectively inhibit ZAK protein kinase, and then regulate the activation of multiple pathways such as JNK/SAPK, p38, ERK, etc. downstream, and can be used for the preparation and prevention of ZAK kinase-related multiple Drugs for various diseases, such as myocardial hypertrophy, myocardial fibrosis, angina pectoris, coronary heart disease, heart failure, myocardial infarction, etc., have good pharmacokinetics and low toxicity, and have high druggability.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111393433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111393433-B
priorityDate 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105431436-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102341102-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105732614-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147989578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148654948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44630709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426273069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409521235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411674012

Total number of triples: 38.